Systematic literature review of clinical outcomes, health-related quality of life, and healthcare costs and resource use in relapsed/refractory large B-cell lymphoma treated with axicabtagene ciloleucel
Leukemia & Lymphoma | July 27, 2026 | Volume: No volume available | Issue: No issue available | Pages: 1-16
10.1080/10428194.2026.2695323
| PMID 42507490